Computed tomography (CT), Magnetic resonance imaging (MRI), Ultrasound, Positron emission tomography), By Agent Type (Radiopharmaceuticals, Contrast Media, Magnetic Resonance Imaging (MRI) Contrast ...

particularly MRI and CT scans, is not always an option, because of the high cost, lack of advanced equipment, and their adverse effects on the body: The contrast agents those methods rely on are ...

Skoltech researchers and their colleagues have synthesized and tested protein-polymer microbubbles for use in medical ultrasound imaging of internal organs. Administered intravenously, the ...

Dong Kook Lifescience lists on KOSDAQ, aims for 300 billion won by 2030 Dong Kook Lifescience seeks to enhance global presence by partnering with AI medical firms and developing innovative imaging ...

The Hà Nội-based Friendship Hospital made a notable impact with the inauguration of its 3.0 Tesla Magnetom Lumina and 1.5 ...

The integration of Polarean's Xenon MRI platform into SimonMed's facilities represents a new business opportunity to expand the availability of functional lung imaging. This collaboration underscores ...

Gadoquatrane, a contrast agent Bayer is developing for use in MRI scans, is able to detect regions of damage and other disease-related features while using 60% less gadolinium — a chemical ...

Gadolinium-based contrast agents (GBCAs) are frequently used in magnetic resonance imaging (MRI) examinations to increase sensitivity in diagnoses. Recently, an increase in the description of ...